Prof. Brit Mollenhauer shares her excitement about basic science, including biomarker research, and how she believes MDS’s diversity can help foster more collaboration between clinicians and basic scientists.
Read MoreDr. Aasef Shaikh shares the exciting developments in the world of tremor and how he believes the use of technology will help answer some of the field’s big questions, including the personalization of treatment.
Read MoreAlpha-synuclein based biomarkers have dominated the Parksinon’s disease field over the past few years. Dr. Andrew Siderowf shares his views on the future of these biomarkers and what else the field may have in store.
Read MoreDr. Victor Fung sat down with Dr. Michele Matarazzo at the #mdscongress to reflect on the advice from his predecessors and how that is helping him achieve his goals as MDS President.
Read MoreDr. Kishore Kumar shares the new genes associated with Parkinson’s disease, dystonia, and ataxia. He also shares how new technologies, like long read sequencing, can assist in finding epigenetic changes.
Read MoreProf. Michael Zech takes a dive into his talk on gene discovery in dystonia. He explains how new findings can provide insight into the pathophysiology of dystonia and improve patient care and treatment.
Read MoreDr. Alexander Lehn breaks down functional movement disorders; what is happening in the brain, what are the potential risk factors and what future treatments and clinical trials we have to look forward to.
Read MoreCredits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-401 Overview: Evidence has shown that exercise can improve mood, but how successful is it for treating depression compared to other therapies? What types and intensities are most effective? Discover insights from a recent meta-analysis on the effects of exercise on depression…
Read More
🎙 Nuevo episodio en «De Piel a Cabeza» en el que hablamos de todo lo relacionado con la salud del pie 👣 En este episodio tan especial, tenemos el placer de conversar con Jesús Serrano, fisioterapeuta y experto en salud podal, autor del reciente libro «La salud a tus pies». Si alguna vez te has…
Read More
El tratamiento hipolipemiante ha demostrado su efectividad en la reducción de eventos cardiovasculares. Sin embargo, alcanzar los niveles objetivo de colesterol LDL sigue siendo un desafío. Factores como la adherencia al tratamiento, la planificación y seguimiento riguroso de los pacientes, además de los efectos secundarios de terapias tradicionales, juegan un papel crucial en este proceso.¿Pueden…
Read More